Oracle, Eli Lilly, and Terawulf Trending Tickers: Job Cuts, AI Expansion, and Biotech Deal

Oracle plans to cut jobs in its cloud division to control costs amid increased spending on AI. Eli Lilly and Terawulf are trending tickers with Lilly signing a $1.3 billion deal with superliminal medicines to develop new treatments using AI. Lilly gets rights to develop and commercialize compounds arising from the collaboration, while Terawulf's stock has surged 50% this year.

Title: Oracle Cuts Cloud Jobs Amid Increased AI Spending; Eli Lilly and TeraWulf Stocks Surge

Oracle (ORCL) has announced plans to reduce jobs in its cloud division to control costs amid increased spending on artificial intelligence (AI) initiatives. The company's cloud division is under pressure to manage expenses as it invests heavily in AI technologies to stay competitive in the market.

The move comes as Oracle partners with Alphabet Inc. (GOOG, GOOGL) to integrate Gemini's AI models into Oracle's applications. This strategic partnership aims to enhance Oracle's cloud services with advanced AI capabilities, positioning it as a leader in AI-driven solutions.

Meanwhile, Eli Lilly (LLY) has been making headlines with its partnership with Superluminal Medicines. The collaboration, valued at $1.3 billion, focuses on developing new weight-loss drugs using AI. Eli Lilly will have exclusive rights to develop and commercialize compounds arising from the collaboration, with Superluminal receiving upfront payments and equity investments [2].

TeraWulf Inc. (WULF) has also seen significant stock growth, with its shares surging over 50% this year. The company has secured two long-term agreements with Fluidstac, a cloud platform that builds and operates high-performance compute (HPC) clusters for global enterprises. Under these agreements, TeraWulf will deliver over 200 megawatts (MW) of high-density IT power at its Lake Mariner campus in Western New York. The contracts are expected to generate around $3.7 billion in revenue during the initial ten-year period [3].

The partnerships and investments in AI technologies reflect the growing trend of companies leveraging AI to drive innovation and competitive advantage. As AI becomes increasingly integral to business operations, companies like Oracle, Eli Lilly, and TeraWulf are positioning themselves at the forefront of this technological revolution.

References
[1] https://finance.yahoo.com/video/c3-ai-downgrade-oracle-alphabet-162108131.html
[2] https://finance.yahoo.com/news/superluminal-medicines-announces-collaboration-eli-120400643.html
[3] https://stocktwits.com/news-articles/markets/equity/terawulf-stock-skyrocketed-15-percent/chsR0fxRdOT